Literature DB >> 29542059

Malignancy probability map as a novel imaging biomarker to predict malignancy distribution: employing MRS in GBM patients.

Manijeh Beigi1,2, Kevan Ghasemi1,2, Parvin Mirzaghavami3, Mohammadreza Khanmohammadi4, Hamidreza SalighehRad5,6.   

Abstract

The main aim of this study was to propose a new statistical method for evaluation of spatial malignancy distribution within Magnetic Resonance Spectroscopy (MRS) grid in Glioblastoma Multiforme patients. Voxels with different malignancy probabilities were presented as a novel MRS-based Malignancy Probability Map (MPM). For this purpose, a predictive probability-based clustering approach was developed, including the two following steps: (1) Gaussian Mixture Model, (2) Quadratic Discriminate Analysis coupled with Genetic Algorithm. Clustered probability values from two methods were then integrated to exploit the MPM. Results show that the suggested method is able to estimate the malignancy distribution with over 90% sensitivity and specificity. The proposed MRS-based MPM has an acceptable accuracy for providing useful complementary information about regional diffuse glioma malignancy, with the potential to lead to better detection of tumoral regions with high probability of malignancy. So, it also may encourage the use of additional information of this map as a tool for dose painting.

Entities:  

Keywords:  Gaussian mixture model; Genetic algorithm; Glioblastoma multiform; Magnetic resonance spectroscopy

Mesh:

Year:  2018        PMID: 29542059     DOI: 10.1007/s11060-018-2829-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  Clinical target volume delineation in glioblastomas: pre-operative versus post-operative/pre-radiotherapy MRI.

Authors:  P Farace; M G Giri; G Meliadò; D Amelio; L Widesott; G K Ricciardi; S Dall'Oglio; A Rizzotti; A Sbarbati; A Beltramello; S Maluta; M Amichetti
Journal:  Br J Radiol       Date:  2010-11-02       Impact factor: 3.039

2.  The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.

Authors:  Jun Guo; Chengjun Yao; Hong Chen; Dongxiao Zhuang; Weijun Tang; Guang Ren; Yin Wang; Jinsong Wu; Fengping Huang; Liangfu Zhou
Journal:  Acta Neurochir (Wien)       Date:  2012-06-23       Impact factor: 2.216

3.  Use of MR spectroscopy and functional imaging in the treatment planning of gliomas.

Authors:  A Narayana; J Chang; S Thakur; W Huang; S Karimi; B Hou; A Kowalski; G Perera; A Holodny; P H Gutin
Journal:  Br J Radiol       Date:  2006-10-26       Impact factor: 3.039

4.  Radiotherapy planning for glioblastoma based on a tumor growth model: improving target volume delineation.

Authors:  Jan Unkelbach; Bjoern H Menze; Ender Konukoglu; Florian Dittmann; Matthieu Le; Nicholas Ayache; Helen A Shih
Journal:  Phys Med Biol       Date:  2014-01-20       Impact factor: 3.609

5.  Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification.

Authors:  K S Opstad; C Ladroue; B A Bell; J R Griffiths; F A Howe
Journal:  NMR Biomed       Date:  2007-12       Impact factor: 4.044

6.  Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.

Authors:  Alexandra Deviers; Soléakhéna Ken; Thomas Filleron; Benjamin Rowland; Andrea Laruelo; Isabelle Catalaa; Vincent Lubrano; Pierre Celsis; Isabelle Berry; Giovanni Mogicato; Elizabeth Cohen-Jonathan Moyal; Anne Laprie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-08-04       Impact factor: 7.038

Review 7.  Imaging biomarkers of brain tumour margin and tumour invasion.

Authors:  S J Price; J H Gillard
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

8.  Compatibility between 3T 1H SV-MRS data and automatic brain tumour diagnosis support systems based on databases of 1.5T 1H SV-MRS spectra.

Authors:  Elies Fuster-Garcia; Clara Navarro; Javier Vicente; Salvador Tortajada; Juan M García-Gómez; Carlos Sáez; Jorge Calvar; John Griffiths; Margarida Julià-Sapé; Franklyn A Howe; Jesús Pujol; Andrew C Peet; Arend Heerschap; Angel Moreno-Torres; M C Martínez-Bisbal; Beatriz Martínez-Granados; Pieter Wesseling; Wolfhard Semmler; Jaume Capellades; Carles Majós; Angel Alberich-Bayarri; Antoni Capdevila; Daniel Monleón; Luis Martí-Bonmatí; Carles Arús; Bernardo Celda; Montserrat Robles
Journal:  MAGMA       Date:  2011-01-20       Impact factor: 2.310

9.  Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma.

Authors:  Maria Consuelo Valentini; Marta Mellai; Laura Annovazzi; Antonio Melcarne; Tetyana Denysenko; Paola Cassoni; Cristina Casalone; Cristiana Maurella; Silvia Grifoni; Piercarlo Fania; Angelina Cistaro; Davide Schiffer
Journal:  Oncotarget       Date:  2017-10-04

Review 10.  Diffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumors.

Authors:  Lu Guo; Gang Wang; Yuanming Feng; Tonggang Yu; Yu Guo; Xu Bai; Zhaoxiang Ye
Journal:  Radiat Oncol       Date:  2016-09-21       Impact factor: 3.481

View more
  1 in total

1.  Characterization of hardware-related spatial distortions for IR-PETRA pulse sequence using a brain specific phantom.

Authors:  Sima Ahmadian; Iraj Jabbari; Seyed Mehdi Bagherimofidi; Hamidreza Saligheh Rad
Journal:  MAGMA       Date:  2020-07-06       Impact factor: 2.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.